Literature DB >> 18931120

Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii.

Mark D Adams1, Karrie Goglin, Neil Molyneaux, Kristine M Hujer, Heather Lavender, Jennifer J Jamison, Ian J MacDonald, Kristienna M Martin, Thomas Russo, Anthony A Campagnari, Andrea M Hujer, Robert A Bonomo, Steven R Gill.   

Abstract

The recent emergence of multidrug resistance (MDR) in Acinetobacter baumannii has raised concern in health care settings worldwide. In order to understand the repertoire of resistance determinants and their organization and origins, we compared the genome sequences of three MDR and three drug-susceptible A. baumannii isolates. The entire MDR phenotype can be explained by the acquisition of discrete resistance determinants distributed throughout the genome. A comparison of closely related MDR and drug-susceptible isolates suggests that drug efflux may be a less significant contributor to resistance to certain classes of antibiotics than inactivation enzymes are. A resistance island with a variable composition of resistance determinants interspersed with transposons, integrons, and other mobile genetic elements is a significant but not universal contributor to the MDR phenotype. Four hundred seventy-five genes are shared among all six clinical isolates but absent from the related environmental species Acinetobacter baylyi ADP1. These genes are enriched for transcription factors and transporters and suggest physiological features of A. baumannii that are related to adaptation for growth in association with humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931120      PMCID: PMC2593238          DOI: 10.1128/JB.00834-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  57 in total

Review 1.  Genomic islands in pathogenic and environmental microorganisms.

Authors:  Ulrich Dobrindt; Bianca Hochhut; Ute Hentschel; Jörg Hacker
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

2.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.

Authors:  Paul Scott; Gregory Deye; Arjun Srinivasan; Clinton Murray; Kimberly Moran; Ed Hulten; Joel Fishbain; David Craft; Scott Riddell; Luther Lindler; James Mancuso; Eric Milstrey; Christian T Bautista; Jean Patel; Alessa Ewell; Tacita Hamilton; Charla Gaddy; Martin Tenney; George Christopher; Kyle Petersen; Timothy Endy; Bruno Petruccelli
Journal:  Clin Infect Dis       Date:  2007-05-08       Impact factor: 9.079

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

Authors:  Shawn R Lockhart; Murray A Abramson; Susan E Beekmann; Gale Gallagher; Stefan Riedel; Daniel J Diekema; John P Quinn; Gary V Doern
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

Review 5.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 6.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

7.  Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains.

Authors:  Alexandr Nemec; Martina Maixnerová; Tanny J K van der Reijden; Peterhans J van den Broek; Lenie Dijkshoorn
Journal:  J Antimicrob Chemother       Date:  2007-06-26       Impact factor: 5.790

8.  Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.

Authors:  Nan-Yao Lee; Hsin-Chun Lee; Nai-Ying Ko; Chia-Ming Chang; Hsin-I Shih; Chi-Jung Wu; Wen-Chien Ko
Journal:  Infect Control Hosp Epidemiol       Date:  2007-05-14       Impact factor: 3.254

9.  Attributable mortality of Acinetobacter baumannii: no longer a controversial issue.

Authors:  Matthew E Falagas; Petros I Rafailidis
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strains.

Authors:  Justin S Hogg; Fen Z Hu; Benjamin Janto; Robert Boissy; Jay Hayes; Randy Keefe; J Christopher Post; Garth D Ehrlich
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  221 in total

1.  Variations of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea.

Authors:  Dae Hun Kim; Young Kyoung Park; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2012-06-05       Impact factor: 5.191

2.  Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors:  Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal:  BMC Genomics       Date:  2011-06-04       Impact factor: 3.969

3.  Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii.

Authors:  Mark D Adams; E Ricky Chan; Neil D Molyneaux; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

4.  Deletion of TnAbaR23 results in both expected and unexpected antibiogram changes in a multidrug-resistant Acinetobacter baumannii strain.

Authors:  Mandira Kochar; Marialuisa Crosatti; Ewan M Harrison; Barbara Rieck; Jacqueline Chan; Chrystala Constantinidou; Mark Pallen; Hong-Yu Ou; Kumar Rajakumar
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

5.  Genotypic and phenotypic correlations of multidrug-resistant Acinetobacter baumannii-A. calcoaceticus complex strains isolated from patients at the National Naval Medical Center.

Authors:  Xiao-Zhe Huang; Jonathan G Frye; Mohamad A Chahine; Dana M Cash; Melissa G Barber; Britta S Babel; Matthew R Kasper; Timothy J Whitman; Luther E Lindler; Robert A Bowden; Mikeljon P Nikolich
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 6.  Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp.

Authors:  Andrew Robinson; Anthony J Brzoska; Kylie M Turner; Ryan Withers; Elizabeth J Harry; Peter J Lewis; Nicholas E Dixon
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

7.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

8.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 9.  Small-Molecule Acetylation by GCN5-Related N-Acetyltransferases in Bacteria.

Authors:  Rachel M Burckhardt; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-15       Impact factor: 11.056

10.  Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.

Authors:  Caitlin L Williams; Heather M Neu; Jeremy J Gilbreath; Sarah L J Michel; Daniel V Zurawski; D Scott Merrell
Journal:  Appl Environ Microbiol       Date:  2016-09-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.